BOS Asset Management LLC Acquires 495 Shares of HCA Healthcare, Inc. (NYSE:HCA)

BOS Asset Management LLC grew its stake in HCA Healthcare, Inc. (NYSE:HCA) by 23.8% during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 2,573 shares of the company’s stock after purchasing an additional 495 shares during the period. BOS Asset Management LLC’s holdings in HCA Healthcare were worth $1,046,000 as of its most recent SEC filing.

A number of other large investors have also made changes to their positions in HCA. CreativeOne Wealth LLC bought a new stake in shares of HCA Healthcare in the 1st quarter worth approximately $231,000. New Mexico Educational Retirement Board increased its holdings in HCA Healthcare by 29.9% in the 1st quarter. New Mexico Educational Retirement Board now owns 13,900 shares of the company’s stock valued at $4,636,000 after buying an additional 3,200 shares during the period. Kingswood Wealth Advisors LLC acquired a new stake in shares of HCA Healthcare during the 1st quarter valued at about $566,000. Bessemer Group Inc. raised its position in HCA Healthcare by 51.2% in the first quarter. Bessemer Group Inc. now owns 7,629 shares of the company’s stock worth $2,543,000 after purchasing an additional 2,584 shares in the last quarter. Finally, Empowered Funds LLC boosted its holdings in HCA Healthcare by 54.3% during the first quarter. Empowered Funds LLC now owns 13,910 shares of the company’s stock valued at $4,639,000 after purchasing an additional 4,893 shares in the last quarter. Institutional investors and hedge funds own 62.73% of the company’s stock.

Insider Buying and Selling

In other news, EVP Michael S. Cuffe sold 8,358 shares of the company’s stock in a transaction that occurred on Thursday, September 12th. The shares were sold at an average price of $385.42, for a total value of $3,221,340.36. Following the completion of the transaction, the executive vice president now owns 29,678 shares in the company, valued at $11,438,494.76. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. In other news, EVP Michael S. Cuffe sold 8,358 shares of the business’s stock in a transaction dated Thursday, September 12th. The stock was sold at an average price of $385.42, for a total value of $3,221,340.36. Following the sale, the executive vice president now directly owns 29,678 shares in the company, valued at $11,438,494.76. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Also, SVP Kathleen M. Whalen sold 2,987 shares of the stock in a transaction dated Wednesday, July 31st. The stock was sold at an average price of $363.51, for a total value of $1,085,804.37. Following the transaction, the senior vice president now owns 9,454 shares of the company’s stock, valued at approximately $3,436,623.54. The trade was a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders sold 17,202 shares of company stock valued at $6,407,273. 1.60% of the stock is owned by corporate insiders.

HCA Healthcare Stock Up 2.0 %

Shares of HCA Healthcare stock opened at $409.23 on Thursday. HCA Healthcare, Inc. has a 12 month low of $215.96 and a 12 month high of $416.72. The business has a fifty day simple moving average of $390.17 and a 200 day simple moving average of $349.03. The company has a quick ratio of 0.94, a current ratio of 1.06 and a debt-to-equity ratio of 27.11. The stock has a market cap of $107.18 billion, a PE ratio of 20.40, a price-to-earnings-growth ratio of 1.44 and a beta of 1.67.

HCA Healthcare (NYSE:HCA) last released its quarterly earnings data on Tuesday, July 23rd. The company reported $5.50 earnings per share for the quarter, topping the consensus estimate of $4.97 by $0.53. The business had revenue of $17.49 billion for the quarter, compared to analyst estimates of $17.05 billion. HCA Healthcare had a net margin of 8.40% and a return on equity of 553.13%. HCA Healthcare’s quarterly revenue was up 10.3% compared to the same quarter last year. During the same quarter last year, the firm earned $4.29 EPS. Research analysts predict that HCA Healthcare, Inc. will post 22.51 EPS for the current year.

HCA Healthcare Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Monday, September 30th. Stockholders of record on Monday, September 16th were given a dividend of $0.66 per share. This represents a $2.64 dividend on an annualized basis and a dividend yield of 0.65%. The ex-dividend date was Monday, September 16th. HCA Healthcare’s dividend payout ratio is currently 13.16%.

Analyst Ratings Changes

Several research firms recently commented on HCA. UBS Group raised their target price on HCA Healthcare from $405.00 to $438.00 and gave the stock a “buy” rating in a research report on Wednesday, August 14th. Royal Bank of Canada upped their target price on shares of HCA Healthcare from $378.00 to $405.00 and gave the stock an “outperform” rating in a report on Friday, August 23rd. Wells Fargo & Company boosted their price target on shares of HCA Healthcare from $315.00 to $365.00 and gave the company an “equal weight” rating in a research report on Tuesday, July 30th. Morgan Stanley assumed coverage on shares of HCA Healthcare in a research note on Tuesday, September 3rd. They issued an “equal weight” rating and a $427.00 target price for the company. Finally, Oppenheimer raised their price target on HCA Healthcare from $345.00 to $390.00 and gave the company an “outperform” rating in a report on Wednesday, July 24th. Five equities research analysts have rated the stock with a hold rating, fourteen have given a buy rating and four have issued a strong buy rating to the company’s stock. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average target price of $365.65.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.